Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.077 | 0.7 |
mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |